✦ LIBER ✦

106 EXTENDED RELEASE NIACIN/LAROPIPRANT LOWERS ATHEROGENIC LIPIDS ACROSS PATIENT SUBGROUPS

✍ Scribed by Ballantyne, C.M.; Bays, H.E.; Shah, A.K.; Sisk, C.; Dong, Q.; Maccubbin, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extended Release Niacin/Laropiprant Lowe

✍ Harold Edward Bays; Christie Ballantyne; Arvind Shah; Christine McCrary Sisk; Qi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 44 KB

The Lipid-Altering Effects of Extended-R

✍ Harold Edward Bays; Alexandra MacLean; Arvind Shah; Christine McCrary Sisk; Qian 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 38 KB

EXTENDED-RELEASE NIACIN/LAROPIPRANT LOWE

✍ Andrew G. Bostom; Darbie Maccubbin; Diane Tipping; Olga Kuznetsova; William A. H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Extended-release niacin/laropiprant lowe

✍ Andrew G. Bostom; Alexandra A. MacLean; Darbie Maccubbin; Diane Tipping; Hilde G 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 202 KB

Extended-Release Niacin/Laropiprant Lowe

✍ Andrew G. Bostom; Alexandra MacLean; Darbie Maccubbin; Diane Tipping; Hilde Gize 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 100 KB

Lipid-modifying efficacy of extended rel

✍ Debra Kush; Hyo-Soo Kim; Da Yi Hu; Ji Liu; Waheeda Sirah; Aditi Sapre; Christine 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 254 KB